Business
Baird Medical Showcases Cutting-Edge MWA Innovations at NASOIE 2025
Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a forward-thinking medical device company specializing in AI-powered surgical robotics and next-generation surgical instruments, and a global leader in microwave ablation (MWA) technology, made a lasting impact at the 2025 North American Society of Interventional Endocrinologists (NASOIE) Annual Meeting in Lehi, Utah.
About this update from Baird Medical Investment Holdings Ltd
[{"type":"text","content":"NEW YORK, March 3, 2025 /PRNewswire/ -- Baird Medical Investment Holdings Ltd. (NASDAQ: BDMD) ("Baird Medical" or the "Company"), a forward-thinking medical device company specializing in AI-powered surgical robotics and next-generation surgical instruments, and a global leader in microwave ablation (MWA) technology, made a lasting impact at the 2025 North American Society of Interventional Endocrinologists (NASOIE) Annual Meeting in Lehi, Utah.","length":474,"tagName":"p"},{"type":"image","alt":"NASOIE","displaySize":"","headline":null,"caption":"NASOIE","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":269,"url":"https://media.zenfs.com/en/prnewswire.com/9f055bccba951bf55fbddb706a4c2879"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/oQH.Sj_ko8VgevNXS.SfIA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTQ3NDtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/9f055bccba951bf55fbddb706a4c2879","width":400,"height":269}},"href":"https://mma.prnewswire.com/media/2631469/BDMD_NASOIE_2025.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"As a premier gathering for experts in interventional endocrinology, NASOIE serves as a platform for advancing minimally invasive treatments for thyroid and parathyroid disorders. The event convenes top-tier clinicians and researchers to explore the latest breakthroughs in treating thyroid nodules and cancer recurrences.","length":321,"tagName":"p"},{"type":"text","content":"Baird Medical's presence at NASOIE 2025 drew strong engagement, with numerous physicians visiting the booth to explore the latest advancements in MWA technology. Attendees participated in hands-on thyroid phantom demonstrations, experiencing firsthand the precision, safety, and efficiency of Baird's technology. The Company's experts engaged in in-depth discussions, addressing key clinical considerations and providing practical insights into MWA's role in thyroid care. Through these interactions, Baird Medical further solidified its leadership in next-generation thyroid ablation therapies, enhancing industry awareness, and reinforcing its commitment to innovation in minimally invasive treatment solutions.","length":729,"tagName":"p"},{"type":"text","content":"Baird Medical remains dedicated to advancing minimally invasive thyroid treatments b...